A subsequent new drug license in India is required for variations of an already approved drug, such as new dosage forms, strengths, indications, or routes of administration. Regulated by CDSCO under the Drugs and Cosmetics Rules, it ensures safety, efficacy, and quality before market approval, facilitating innovation while maintaining stringent regulatory compliance.
.png)
A subsequent new drug license in India is required for variations of an already approved drug, such as new dosage forms, strengths, indications, or routes of administration. Regulated by CDSCO under the Drugs and Cosmetics Rules, it ensures safety, efficacy, and quality before market approval, facilitating innovation while maintaining stringent regulatory compliance.